New program replaces annual compliance cycles with annual assurance, reducing audit fatigue and strengthening fraud defenses for financial institutions. WASHINGTON D ...
Preparations underway to advance AP-101 into confirmatory Phase 3 clinical trial with initiation aimed for late 2026 ZURICH, March 19, 2026--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results